3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan.

[1]  G. Chiara,et al.  Calcium‐Dependent, Tetrodotoxin‐Sensitive Stimulation of Cortical Serotonin Release After a Tryptophan Load , 1989, Journal of neurochemistry.

[2]  R. Roth,et al.  MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin. , 1989, European journal of pharmacology.

[3]  M. D. Schechter Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) , 1988, Pharmacology Biochemistry and Behavior.

[4]  G. Hanson,et al.  Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. , 1988, The Journal of pharmacology and experimental therapeutics.

[5]  B. Yamamoto,et al.  The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. , 1988, European journal of pharmacology.

[6]  Peroutka Sj Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus. , 1987 .

[7]  M. D. Simoni,et al.  Functional meaning of tryptophan-induced increase of 5-HT metabolism as clarified by in vivo voltammetry , 1987, Brain Research.

[8]  L S Seiden,et al.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. , 1987, The Journal of pharmacology and experimental therapeutics.

[9]  W. Lovenberg,et al.  In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. , 1987, Biochemical pharmacology.

[10]  B. Hoebel,et al.  A small, removable microdialysis probe. , 1986, Life sciences.

[11]  D. E. Nichols,et al.  Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class. , 1986, Journal of medicinal chemistry.

[12]  G. Hanson,et al.  The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. , 1986, European journal of pharmacology.

[13]  W. Lovenberg,et al.  Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue. , 1986, European journal of pharmacology.

[14]  P. Lipton,et al.  Regulation of Serotonin Release from the In Vitro Rat Hippocampus: Effects of Alterations in Levels of Depolarization and in Rates of Serotonin Metabolism , 1985, Journal of neurochemistry.

[15]  G. Aghajanian,et al.  Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices , 1983, Brain Research.

[16]  J. B. Justice,et al.  Interpretations of Voltammetry in the Striatum Based on Chromatography of Striatal Dialysate , 1983 .

[17]  G. Aghajanian,et al.  Intracellular identification of central noradrenergic and serotonergic neurons by a new double labeling procedure , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  H. F. Schott,et al.  [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats. , 1982, Biochemical pharmacology.

[19]  H. Nakata,et al.  Purification and properties of tryptophan 5-monooxygenase from rat brain-stem. , 1982, European journal of biochemistry.

[20]  B. Yamamoto,et al.  A frequency analysis of behavior components of the serotonin syndrome produced by p-chloroamphetamine , 1979, Pharmacology Biochemistry and Behavior.

[21]  H. Haas,et al.  A simple perfusion chamber for the study of nervous tissue slices in vitro , 1979, Journal of Neuroscience Methods.

[22]  W. W. Youngblood,et al.  Serotonin synthesis and release in brain slices: Independence of tryptophan , 1979, Brain Research.

[23]  M. Boadle-Biber Activation of tryptophan hydroxylase from central serotonergic neurons by calcium and depolarization. , 1978, Biochemical pharmacology.

[24]  G. Aghajanian,et al.  Inhibition of firing of raphe neurones by tryptophan and 5-hydroxytryptophan: Blockade by inhibiting serotonin synthesis with Ro-4-4602 , 1976, Neuropharmacology.

[25]  M. Hamon,et al.  In vivo release of 5-HT in the lateral ventricle of the rat: effects of 5-hydroxytryptophan and tryptophan , 1976, Brain Research.

[26]  K. E. Moore,et al.  D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo. , 1975, The Journal of pharmacology and experimental therapeutics.

[27]  P. Knott,et al.  EFFECT OF INCREASED RAT BRAIN TRYPTOPHAN ON 5‐HYDROXYTRYPTAMINE AND 5‐HYDROXYINDOLYL ACETIC ACID IN THE HYPOTHALAMUS AND OTHER BRAIN REGIONS , 1974, Journal of neurochemistry.

[28]  S. Kaufman,et al.  Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. , 1972, The Journal of biological chemistry.

[29]  R. Wurtman,et al.  Brain Serotonin Content: Physiological Dependence on Plasma Tryptophan Levels , 1971, Science.

[30]  A. Carlsson,et al.  Accumulation of 5‐hydroxytryptophan in mouse brain after decarboxylase inhibition , 1970, The Journal of pharmacy and pharmacology.

[31]  G. Aghajanian,et al.  Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices , 1989, Synapse.

[32]  C. J. Schmidt,et al.  Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. , 1987, The Journal of pharmacology and experimental therapeutics.